RVL Pharmaceuticals plc Comprehensive Income
RVL Pharmaceuticals plc reported Comprehensive Income of -$23.89 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-08-14
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$23.89M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$11.61M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$18.32M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-09-30 was -$14.45M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$53.39M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$60.99M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$79.59M.
- RVL Pharmaceuticals plc comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$110.89M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$23.89M 10-Q · filed 2023-08-14 | -$35.50M 10-Q · filed 2023-08-14 | -$53.82M derived: sum of 3 quarters · filed 2023-08-14 | -$68.27M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$11.61M 10-Q · filed 2023-05-11 | -$29.93M derived: sum of 2 quarters · filed 2023-05-11 | -$44.38M derived: sum of 3 quarters · filed 2023-05-11 | -$56.48M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$32.77M derived: sum of 2 quarters · filed 2023-03-20 | -$44.87M derived: sum of 3 quarters · filed 2023-08-14 | -$53.39M 10-K · filed 2023-03-20 | ||||
| 2022-09-30 | -$14.45M 10-Q · filed 2022-11-10 | -$26.55M derived: sum of 2 quarters · filed 2023-08-14 | -$35.07M 10-Q · filed 2022-11-10 | -$50.87M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | -$12.11M 10-Q · filed 2023-08-14 | -$20.63M 10-Q · filed 2023-08-14 | -$36.42M derived: sum of 3 quarters · filed 2023-08-14 | -$54.28M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$8.52M 10-Q · filed 2023-05-11 | -$24.31M derived: sum of 2 quarters · filed 2023-05-11 | -$42.17M derived: sum of 3 quarters · filed 2023-05-11 | -$59.90M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$33.65M derived: sum of 2 quarters · filed 2023-03-20 | -$51.38M derived: sum of 3 quarters · filed 2023-03-20 | -$60.99M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$17.86M 10-Q · filed 2022-11-10 | -$35.59M derived: sum of 2 quarters · filed 2022-11-10 | -$45.20M 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$17.73M 10-Q · filed 2022-08-11 | -$27.34M 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$9.61M 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$79.59M 10-K · filed 2022-03-30 | |||||||
| 2019-12-31 | -$26.64M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$139.73M derived: sum of 2 quarters · filed 2021-09-08 | -$264.60M derived: sum of 3 quarters · filed 2021-09-08 | -$271.28M 8-K · filed 2021-09-08 | ||||
| 2019-09-30 | -$113.09M 10-Q · filed 2019-11-14 | -$237.96M derived: sum of 2 quarters · filed 2020-08-11 | -$244.64M 10-Q · filed 2019-11-14 | -$351.62M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-06-30 | -$124.87M 10-Q · filed 2020-08-11 | -$124.65M 10-Q · filed 2019-08-08 | -$131.56M 10-Q · filed 2020-08-11 | -$130.85M 10-Q · filed 2019-08-08 | -$238.54M derived: sum of 3 quarters · filed 2020-08-11 | -$242.29M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | -$6.69M 10-Q · filed 2020-05-12 | -$6.20M 10-Q · filed 2019-05-09 | -$113.67M derived: sum of 2 quarters · filed 2020-05-12 | -$117.42M derived: sum of 3 quarters · filed 2020-05-12 | -$112.43M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$106.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$110.73M derived: sum of 2 quarters · filed 2020-03-19 | -$105.74M derived: sum of 3 quarters · filed 2020-03-19 | -$110.89M 10-K · filed 2020-03-19 | -$110.61M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | -$3.75M 10-Q · filed 2019-11-14 | -$5.14M 10-Q · filed 2018-11-08 | $1.24M derived: sum of 2 quarters · filed 2019-11-14 | -$3.91M 10-Q · filed 2019-11-14 | -$4.81M 10-Q · filed 2018-11-08 | -$3.51M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-06-30 | $4.99M 10-Q · filed 2019-11-14 | $5.17M 10-Q · filed 2019-08-08 | -$159.33K 10-Q · filed 2019-11-14 | $190.41K 10-Q · filed 2019-08-08 | $242.32K derived: sum of 3 quarters · filed 2019-12-20 | -$13.44M derived: sum of 4 quarters · filed 2019-12-20 | ||
| 2018-03-31 | -$5.15M 10-Q · filed 2019-11-14 | -$4.98M 10-Q · filed 2019-05-09 | -$4.75M derived: sum of 2 quarters · filed 2019-12-20 | -$18.43M derived: sum of 3 quarters · filed 2019-12-20 | ||||
| 2017-12-31 | $401.65K derived: 8-K 12 month − 10-K 9 month · filed 2019-12-20 | -$13.28M derived: sum of 2 quarters · filed 2019-12-20 | -$42.16M 8-K · filed 2019-12-20 | -$42.05M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$13.68M 10-K · filed 2019-03-28 | -$11.98M 10-Q · filed 2018-11-08 | -$42.56M 10-K · filed 2019-03-28 | -$41.92M 10-Q · filed 2018-11-08 |